- Zacks via Yahoo FinanceNov 13 18:14 PM
AVEO Pharmaceuticals, Inc. AVEO reported earnings of 10 cents per share in the third quarter of 2019, surpassing the Zacks Consensus Estimate of 1 cent. It also rebounded from the year-ago loss of 18 cents.
- Market Watch2 days ago
Global Women's Health Market 2020: Key Stakeholders, Sub-Component Manufacturers, Industry Association 2029Market Watch3 days ago
Blood Analyzers Market SWOT analysis & Key Business Strategies | Sysmex, Medtronic, Bayer AG, Danaher, AbbottMarket Watch3 days ago
- Reuters via Yahoo FinanceNov 13 14:09 PM
Its technology has attracted a bevy of partners including Novartis AG, Merck & Co and Shionogi & Co.
- Bloomberg via Yahoo FinanceNov 13 10:45 AM
Almost exactly a year after Unilever NV announced the departure of chief executive officer Paul Polman, the consumer goods giant’s chairman Marijn Dekkers is stepping down with immediate effect ...
- Zacks via Yahoo FinanceNov 12 12:59 PM
The sBLA is seeking to get the dual immuno-oncology therapy approved in patients with advanced hepatocellular carcinoma (“HCC”), previously treated with Bayer's BAYRY chemotherapy, Nexavar ...
- Reuters via Yahoo FinanceNov 14 2:22 AM
The promise of PeptiDream Inc's drug-discovery technology and its lucrative research-for-hire contracts have made it a darling of the Tokyo stock market. Now, those gains have made it a target for short-seller Muddy Waters.